264 related articles for article (PubMed ID: 23851919)
1. Myocardial structure, function and ischaemic tolerance in a rodent model of obesity with insulin resistance.
Wensley I; Salaveria K; Bulmer AC; Donner DG; du Toit EF
Exp Physiol; 2013 Nov; 98(11):1552-64. PubMed ID: 23851919
[TBL] [Abstract][Full Text] [Related]
2. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F
Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553
[TBL] [Abstract][Full Text] [Related]
3. Ischaemic post-conditioning protects both adult and aged Sprague-Dawley rat heart from ischaemia-reperfusion injury through the phosphatidylinositol 3-kinase-AKT and glycogen synthase kinase-3beta pathways.
Yin Z; Gao H; Wang H; Li L; Di C; Luan R; Tao L
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):756-63. PubMed ID: 19207715
[TBL] [Abstract][Full Text] [Related]
4. Effect of chronic CPT-1 inhibition on myocardial ischemia-reperfusion injury (I/R) in a model of diet-induced obesity.
Maarman G; Marais E; Lochner A; du Toit EF
Cardiovasc Drugs Ther; 2012 Jun; 26(3):205-16. PubMed ID: 22407171
[TBL] [Abstract][Full Text] [Related]
5. Cordycepin, 3'-deoxyadenosine, prevents rat hearts from ischemia/reperfusion injury via activation of Akt/GSK-3β/p70S6K signaling pathway and HO-1 expression.
Park ES; Kang DH; Yang MK; Kang JC; Jang YC; Park JS; Kim SK; Shin HS
Cardiovasc Toxicol; 2014 Mar; 14(1):1-9. PubMed ID: 24178833
[TBL] [Abstract][Full Text] [Related]
6. Myocardial susceptibility to ischaemia/reperfusion in obesity: a re-evaluation of the effects of age.
Webster I; Salie R; Marais E; Fan WJ; Maarman G; Huisamen B; Lochner A
BMC Physiol; 2017 Mar; 17(1):3. PubMed ID: 28302152
[TBL] [Abstract][Full Text] [Related]
7. A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury.
du Toit EF; Nabben M; Lochner A
Basic Res Cardiol; 2005 Jul; 100(4):346-54. PubMed ID: 15821998
[TBL] [Abstract][Full Text] [Related]
8. Obesity improves myocardial ischaemic tolerance and RISK signalling in insulin-insensitive rats.
Donner D; Headrick JP; Peart JN; du Toit EF
Dis Model Mech; 2013 Mar; 6(2):457-66. PubMed ID: 23161371
[TBL] [Abstract][Full Text] [Related]
9. Ventricular hypertrophy abrogates intralipid-induced cardioprotection by alteration of reperfusion injury salvage kinase/glycogen synthase kinase 3β signal.
Ma LL; Ge HW; Kong FJ; Qian LB; Hu BC; Li Q; Xu L; Liu JQ; Xu YX; Sun RH
Shock; 2014 May; 41(5):435-42. PubMed ID: 24430545
[TBL] [Abstract][Full Text] [Related]
10. Pravastatin improves risk factors but not ischaemic tolerance in obese rats.
Oi M; Donner D; Peart J; Beck B; Wendt L; Headrick JP; du Toit EF
Eur J Pharmacol; 2018 May; 826():148-157. PubMed ID: 29501869
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
Gonon AT; Widegren U; Bulhak A; Salehzadeh F; Persson J; Sjöquist PO; Pernow J
Cardiovasc Res; 2008 Apr; 78(1):116-22. PubMed ID: 18222959
[TBL] [Abstract][Full Text] [Related]
12. Myocardial susceptibility to ischemic-reperfusion injury in a prediabetic model of dietary-induced obesity.
du Toit EF; Smith W; Muller C; Strijdom H; Stouthammer B; Woodiwiss AJ; Norton GR; Lochner A
Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2336-43. PubMed ID: 18359896
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of glycogen synthase kinase-3beta improves tolerance to ischemia in hypertrophied hearts.
Barillas R; Friehs I; Cao-Danh H; Martinez JF; del Nido PJ
Ann Thorac Surg; 2007 Jul; 84(1):126-33. PubMed ID: 17588398
[TBL] [Abstract][Full Text] [Related]
15. Insulin protects isolated hearts from ischemia/reperfusion injury: cross-talk between PI3-K/Akt and JNKs.
Liu HT; Zhang HF; Si R; Zhang QJ; Zhang KR; Guo WY; Wang HC; Gao F
Sheng Li Xue Bao; 2007 Oct; 59(5):651-9. PubMed ID: 17940706
[TBL] [Abstract][Full Text] [Related]
16. Aprotinin abolishes sevoflurane postconditioning by inhibiting nitric oxide production and phosphorylation of protein kinase C-delta and glycogen synthase kinase 3beta.
Inamura Y; Miyamae M; Sugioka S; Kaneda K; Okusa C; Onishi A; Domae N; Kotani J; Figueredo VM
Anesthesiology; 2009 Nov; 111(5):1036-43. PubMed ID: 19809279
[TBL] [Abstract][Full Text] [Related]
17. Acute PKCdelta inhibition limits ischaemia-reperfusion injury in the aged rat heart: role of GSK-3beta.
Kostyak JC; Hunter JC; Korzick DH
Cardiovasc Res; 2006 May; 70(2):325-34. PubMed ID: 16542646
[TBL] [Abstract][Full Text] [Related]
18. Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion.
Kovacs K; Toth A; Deres P; Kalai T; Hideg K; Gallyas F; Sumegi B
Biochem Pharmacol; 2006 Feb; 71(4):441-52. PubMed ID: 16337154
[TBL] [Abstract][Full Text] [Related]
19. The consequences of long-term glycogen synthase kinase-3 inhibition on normal and insulin resistant rat hearts.
Flepisi TB; Lochner A; Huisamen B
Cardiovasc Drugs Ther; 2013 Oct; 27(5):381-92. PubMed ID: 23820981
[TBL] [Abstract][Full Text] [Related]
20. Effect of pressure overload on cardioprotection via PI3K-Akt: comparison of postconditioning, insulin, and pressure unloading.
Mozaffari MS; Liu JY; Schaffer SW
Am J Hypertens; 2010 Jun; 23(6):668-74. PubMed ID: 20300072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
